Eldorado Issues Proxy Circular Soliciting Blue Proxies to Vote Against Approval of Frontier's Poison Pill-ISS Canada Also Recommends That Shareholders Vote Against...

Paul N. Wright, President and Chief Executive Officer of Eldorado Gold Corporation ("Eldorado") (TSX: ELD)(AMEX: EGO) announced today that Eldorado has mailed to shareholders of Frontier Pacific Mining Corporation ("Frontier") and filed on SEDAR, an information circular and BLUE form of proxy (the "Circular and Proxy") relating to a general meeting of Frontier shareholders to be held on June 19, 2008 (the "Meeting"). Frontier management have called the Meeting in order to adopt and confirm a "tactical" shareholder rights plan - more commonly referred to as a "Poison Pill" - adopted by Frontier on May 16, 2008 in direct response to the offer (the "Offer") by Eldorado to purchase all of the issued and outstanding common shares of Frontier.

Eldorado believes that Frontier's Poison Pill does not enhance shareholder value and serves no purpose other than to entrench Frontier's current management and to deny Frontier's shareholders the opportunity to tender to a fair and full Offer at an attractive premium. Accordingly, Eldorado has sent the Circular and Proxy to Frontier shareholders to solicit votes against approval and confirmation of the Poison Pill.

Frontier has stated that its principal reason for adopting the Poison Pill is to provide Frontier's management with the time required to find an alternative transaction to the Offer. However, as of the June 17, 2008 expiry date of Eldorado's Offer, Frontier's management will have had 60 days to find alternative transactions since the time they learned of Eldorado's current Offer and nearly two years since Eldorado first approached Frontier to propose a business combination. Eldorado believes that Frontier's management has had ample time to find alternatives to the Offer, and notes that they have thus far failed to present a single one.

Eldorado also notes that Institutional Shareholder Services Canada Corp. ("ISS Canada") has recommended that Frontier shareholders vote against approval and confirmation of the Poison Pill. In a report published on June 3, 2008, ISS Canada stated that the Poison Pill, "provides the board and management with excessive opportunity to interpret provisions of the plan. This plan does not allow shareholders enough control of the process to sufficiently safeguard their interests." ISS Canada is a wholly-owned subsidiary of Institutional Shareholder Services Inc. ("ISS"). ISS is one of the world's leading providers of corporate governance and proxy voting solutions. It provides proxy research, voting services and corporate governance advisory services to financial institutions and corporations worldwide(i).

Eldorado's President and Chief Executive Officer, Paul N. Wright, commented, "We are pleased with the ISS Canada recommendation. It validates Eldorado's position that this Poison Pill does not advance the interests of Frontier's shareholders and should be voted down."

If Frontier's Poison Pill is not waived, voted down or otherwise terminated prior to the time of expiry of Eldorado's Offer, the Offer will terminate in accordance with its terms. Therefore, Frontier shareholders who tender to Eldorado's Offer must also vote against Frontier's Poison Pill.

Eldorado urges Frontier shareholders to seriously consider the risks and uncertainties Frontier will face if the Poison Pill is approved and Eldorado's Offer expires, including the prospect of a collapse of Frontier's current share price to pre-offer prices. Prior to Eldorado's announcement that it intended to make the Offer, the 20-day volume weighted average price for Frontier shares on the TSX Venture Exchange was C$0.668 per share. Since Eldorado announced its intention to make the Offer, Frontier's share price has increased substantially and has since traded at higher levels supported by Eldorado's Offer. Based on the closing price of Eldorado's common shares on the Toronto Stock Exchange on June 9, 2008, the Offer now represents a premium of 53.0% to the price of Frontier shares on the TSX Venture Exchange on April 18, 2008, the last trading day prior to the announcement of the Offer.

Eldorado's Offer remains open for acceptance until 5:00 p.m. (Toronto time) on June 17, 2008, unless extended or withdrawn. Frontier shareholders wishing to accept the Offer are encouraged to tender their shares by completing the letter of transmittal accompanying the documents mailed to them and returning it together with certificates representing their Frontier shares and all other documents to the offices of Kingsdale Shareholder Services Inc. in Toronto, Ontario in accordance with the instructions in the letter of transmittal. If Frontier shares are held by a broker or other financial intermediary, Frontier shareholders should contact such intermediary and instruct it to tender their Frontier shares.

Proxy Voting

Frontier shareholders are reminded to vote the BLUE proxy and to return it to Kingsdale Shareholder Services Inc. in accordance with the instructions set out in the Circular and Proxy, by no later than Monday, June 16, 2008.